Ocado shareholders hope results bring news of progress
The Week Ahead
Your support helps us to tell the story
This election is still a dead heat, according to most polls. In a fight with such wafer-thin margins, we need reporters on the ground talking to the people Trump and Harris are courting. Your support allows us to keep sending journalists to the story.
The Independent is trusted by 27 million Americans from across the entire political spectrum every month. Unlike many other quality news outlets, we choose not to lock you out of our reporting and analysis with paywalls. But quality journalism must still be paid for.
Help us keep bring these critical stories to light. Your support makes all the difference.
Long-suffering shareholders of Ocado will hope that tomorrow’s annual results bring news of progress in the online supermarket’s pursuit of its first deal overseas.
The FTSE 250 company had promised to sign a deal with a foreign partner last year to match its current licensing deals with the UK supermarket chains Morrisons and Waitrose.
However, with no sign of an agreement and the threat of Amazon’s arrival in the UK grocery market, investors have become increasingly anxious and the shares have suffered accordingly, down 30 per cent over the past couple of months.
Of course, the short-sellers in Ocado, of which there are many, are hoping for more delays. A sizeable 16.7 per cent of the firm’s shares are on loan to investors hoping the share price will fall so they can buy them back at a cheaper price for profit.
However, if Amazon attempts to buy the company on the cheap – as vague speculation has hinted it might – their efforts will be thwarted.
Today, telecoms giant BT, which has just completed its £12.5bn takeover of mobile operator EE, announces its third-quarter results. The regulator may have waved through the deal for EE, but Ofcom is currently investigating whether BT should split off Openreach, which controls the last mile of fibre that runs to homes.
Tomorrow, BP will reveal the impact of lower oil prices on its fourth-quarter results.
On Wednesday, drugs giant GlaxoSmithKline unveils fourth-quarter results, amid speculation that chief executive Sir Andrew Witty is considering offloading its consumer healthcare arm – with Reckitt Benckiser, Unilever and Proctor & Gamble all said to be interested.
Other notable releases this week include a third-quarter trading statement from catalytic converter maker Johnson Matthey on Wednesday, and a trading update from Vodafone on Thursday.
Across the Atlantic, Google parent Alphabet brings out its fourth-quarter earnings tomorrow, as does supercar maker Ferrari.
Global markets are likely to take their lead from China, which brings out manufacturing data for January. This is expected to show an improvement on December but the sector will still be contracting.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments